Allscripts Healthcare Solutions (NASDAQ:MDRX) was downgraded by equities researchers at Thomson Reuters/Verus from a “hold” rating to a “sell” rating in a research report issued on Monday, American Banking and Market News reports.
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded down 1.43% on Monday, hitting $14.50. 345,732 shares of the company’s stock traded hands. Allscripts Healthcare Solutions has a one year low of $8.85 and a one year high of $16.43. The stock’s 50-day moving average is $15.2 and its 200-day moving average is $14.01. The company’s market cap is $2.576 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.02. The company had revenue of $344.80 million for the quarter, compared to the consensus estimate of $360.00 million. During the same quarter in the previous year, the company posted $0.16 earnings per share. The company’s revenue for the quarter was down 6.8% on a year-over-year basis. On average, analysts predict that Allscripts Healthcare Solutions will post $0.33 earnings per share for the current fiscal year.
A number of other firms have also recently commented on MDRX. Analysts at Stephens initiated coverage on shares of Allscripts Healthcare Solutions in a research note to investors on Thursday, October 17th. They set an “equal weight” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Allscripts Healthcare Solutions in a research note to investors on Thursday, September 19th. They now have a $15.00 price target on the stock. Finally, analysts at KeyCorp initiated coverage on shares of Allscripts Healthcare Solutions in a research note to investors on Wednesday, September 4th. They set a “hold” rating on the stock. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $15.54.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.